Gene transfer into the mouse retina mediated by an adeno-associated viral vector
- PMID: 8733124
- DOI: 10.1093/hmg/5.5.591
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Abstract
Gene transfer to photoreceptor cells may provide a means for arresting the retinal degeneration that is characteristic of many inherited causes of blindness, including retinitis pigmentosa (RP). However, transduction of photoreceptors has to date been inefficient, and further limited by toxicity and immune responses directed against vector-specific proteins. An alternative vector system based on adeno-associated virus (AAV) may obviate these problems, and may be useful for transduction of neuronal cells. In this study we have demonstrated successful transduction of all layers of the neuroretina as well as the retinal pigment epithelium (RPE) following subretinal injection of recombinant AAV particles encoding lac Z. Furthermore, the efficiency of transduction of photoreceptors is significantly higher than that achieved with an equivalent adenoviral vector. This is the first report showing that AAV is capable of transducing photoreceptor cells and supports the use of this vector system for gene therapy of retinal diseases such as RP.
Similar articles
-
Adeno-associated virus gene transfer to mouse retina.Hum Gene Ther. 1998 Jan 1;9(1):81-6. doi: 10.1089/hum.1998.9.1-81. Hum Gene Ther. 1998. PMID: 9458245
-
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.Curr Eye Res. 1997 Sep;16(9):949-56. doi: 10.1076/ceyr.16.9.949.5046. Curr Eye Res. 1997. PMID: 9288458
-
AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.Mol Ther. 2001 Feb;3(2):241-8. doi: 10.1006/mthe.2000.0252. Mol Ther. 2001. PMID: 11237681
-
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.Eur J Pharm Biopharm. 2015 Sep;95(Pt B):343-52. doi: 10.1016/j.ejpb.2015.01.009. Epub 2015 Jan 20. Eur J Pharm Biopharm. 2015. PMID: 25615882 Review.
-
Novel adeno-associated viral vectors for retinal gene therapy.Gene Ther. 2012 Feb;19(2):162-8. doi: 10.1038/gt.2011.151. Epub 2011 Oct 13. Gene Ther. 2012. PMID: 21993172 Review.
Cited by
-
Adeno-associated virus vectors for retinal gene therapy in basic research and clinical studies.Front Med (Lausanne). 2023 Dec 1;10:1310050. doi: 10.3389/fmed.2023.1310050. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38105897 Free PMC article. Review.
-
Hot topics in adeno-associated virus as a gene transfer vector.Mol Biotechnol. 2001 Nov;19(3):229-37. doi: 10.1385/MB:19:3:229. Mol Biotechnol. 2001. PMID: 11721619 Review.
-
[Viral and nonviral gene therapy for treatment of retinal diseases].Ophthalmologe. 2005 Aug;102(8):764-71. doi: 10.1007/s00347-005-1245-z. Ophthalmologe. 2005. PMID: 16012813 Review. German.
-
Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy.Sci Rep. 2014 Jan 24;4:3759. doi: 10.1038/srep03759. Sci Rep. 2014. PMID: 24457557 Free PMC article.
-
Gene therapy for inherited retinal degeneration.Br J Ophthalmol. 1997 Sep;81(9):795-801. doi: 10.1136/bjo.81.9.795. Br J Ophthalmol. 1997. PMID: 9422936 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources